Fineotex Chemical targets USD 100 million from US ops in FY27
Fineotex Chemical Limited delivered strong Q1FY27 results with PAT rising 93% YoY to ₹48.21 crore, driven by its US oilfield chemicals business. Management confirmed 63% capacity utilization at the Texas facility and reiterated guidance for USD 100 million in US revenue for FY27.

*this image is generated using AI for illustrative purposes only.
Fineotex Chemical Limited reported a consolidated profit after tax (PAT) of ₹48.21 crore for Q1FY27, a 92.67% year-on-year increase, driven by robust performance in its US-based oilfield specialty chemicals business. During the earnings conference call held on July 24, 2026, management revealed that the Texas facility is operating at 63% capacity utilization of its newly expanded 148,000 MTPA capacity. The company reaffirmed its guidance to achieve USD 100 million in revenue from its US operations in FY27 and USD 200 million in FY28, citing strong order books and successful integration of CrudeChem Technologies Group.
Executive Director and CFO Sanjay Tibrewala stated that the US operations contributed approximately 65% of the total consolidated revenue in the quarter, amounting to roughly ₹250 crore. He emphasized that the growth trajectory is supported by improved execution capabilities and scalability under Fineotex’s management. The Board of Directors approved the unaudited financial results on July 23, 2026, following a review by the Audit Committee and statutory auditors ASL & Co. Chartered Accountants.
Operational Efficiency and Capacity Utilization
The commissioning of additional capacity at the Texas plant has increased total manufacturing capability to approximately 148,000 metric tons per year. Management noted that current utilization stands at 63% on a single-shift basis, with potential to scale further through double shifts without significant capital expenditure. Tibrewala indicated that incremental investments for scaling would be minimal, estimated at USD 1–2 million, which is negligible against the company’s cash reserves.
| Metric | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹376.63 Cr | ₹137.07 Cr | +174.77% |
| Gross Profit | ₹133.40 Cr | ₹45.96 Cr | +190.25% |
| EBITDA | ₹59.14 Cr | ₹25.20 Cr | +134.70% |
| EBITDA Margin | 15.70% | 18.38% | -268 bps |
| Profit After Tax | ₹48.21 Cr | ₹25.03 Cr | +92.67% |
Strategic Outlook and Margin Dynamics
Management clarified that the blended EBITDA margin of 15.70% reflects the integration phase of the US business, with standalone US margins estimated between 13% and 14%. Tibrewala stated that the company does not provide fixed margin guidance due to the diverse product basket of over 100 categories, but aims for long-term profitability improvements through operational synergies. The working capital cycle was maintained at 72 days, reflecting disciplined capital management.
What the Numbers Show
The financial results highlight a structural shift in Fineotex’s revenue composition, with international operations now dominating the top line. While standalone Indian revenue saw a marginal decline due to seasonal factors and accounting norms regarding the new FSPL Specialties Private Limited plant, the consolidated view shows strong growth. The acquisition of CrudeChem has been pivotal, with management noting that natural hedging through dollar-denominated imports and exports mitigates foreign exchange volatility. The focus remains on expanding wallet share with major service operators and leveraging last-mile delivery capabilities via Trackmax to enhance customer stickiness in the North American market.
Historical Stock Returns for Fineotex Chemical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.12% | +4.25% | +21.63% | +79.38% | +85.67% | +314.61% |
How does Fineotex plan to accelerate capacity utilization from 63% to higher levels without significant capex, and what are the primary bottlenecks preventing immediate double-shift operations?
What specific operational synergies or cost-saving measures are expected to drive the improvement in standalone US EBITDA margins from the current 13-14% range over the next two fiscal years?
Given the reliance on major service operators in North America, how exposed is Fineotex's US revenue to potential downturns in global oil and gas exploration and production spending?


































